CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 20,370 shares at $1.29 ($26,277)
- 4 Open-market sale SVP, BIOLOGICS OPERATIONS sold 12,000 shares at $3.55 ($42,600)
- 4 Open-market sale SVP, BIOLOGICS OPERATIONS sold 44,593 shares at an average $3.58 ($159,709)
- 4 Open-market buy PRESIDENT, CEO bought 40,000 shares at $25.00 ($1,000,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company Director returned 13,333 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award 10% owner acquired 1,132,653 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Exec. VC - Strategic Dev. acquired 552,698 shares (grant or award)
- 4 Open-market buy President and CEO bought 731 shares at $2.03 ($1,484)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 15 · 289 filings